BCL2L1 and neoplasm: Three weeks after the adoptive cell transfer, we observed that more CEA-reactive CD8+ T cells accumulated in MC-32 tumor tissues in mice receiving CEA CAR-T cells overexpressing Bcl-xL than those receiving the CEA CAR-T cells without overexpressing Bcl-xL or the non-specific T cell control (Figure 6).